Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ProPhase Labs Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
PRPH
Nasdaq
2833
https://www.prophaselabs.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ProPhase Labs Inc
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript
- Mar 18th, 2024 1:20 pm
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
- Mar 18th, 2024 1:08 pm
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
- Mar 15th, 2024 12:00 pm
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
- Mar 8th, 2024 1:00 pm
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 29% Above Their Intrinsic Value Estimate
- Mar 1st, 2024 11:28 am
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test DevelopmentĀ USPTO grants additional broad patents for BE-SMART
- Feb 20th, 2024 1:00 pm
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
- Feb 14th, 2024 1:00 pm
Diamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI)
- Feb 8th, 2024 1:00 pm
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
- Jan 30th, 2024 1:00 pm
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
- Jan 23rd, 2024 1:00 pm
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
- Jan 4th, 2024 1:00 pm
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript
- Nov 10th, 2023 6:50 pm
ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic Transformations
- Nov 9th, 2023 2:25 pm
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023
- Nov 9th, 2023 1:00 pm
ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time
- Nov 2nd, 2023 12:00 pm
ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.
- Oct 17th, 2023 12:00 pm
DSS Inc. Issues Letter to Shareholders
- Oct 12th, 2023 12:25 pm
ProPhase Labs to Present at The ThinkEquity Conference
- Oct 12th, 2023 12:00 pm
Are ProPhase Labs, Inc. (NASDAQ:PRPH) Investors Paying Above The Intrinsic Value?
- Aug 31st, 2023 10:17 am
ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.
- Aug 10th, 2023 2:40 pm
Scroll